BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 824198)

  • 21. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 22. An effector-cell independent step in target cell lysis by sensitized mouse lymphocytes.
    Martz E; Benacerraf B
    J Immunol; 1973 Nov; 111(5):1538-45. PubMed ID: 4200780
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells.
    Henney CS
    J Immunol; 1971 Dec; 107(6):1558-66. PubMed ID: 5000987
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
    Wright SC; Bonavida B
    J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.
    Orsini F; Eppolito C; Ehrke MJ; Mihich E
    Cancer Treat Rep; 1980; 64(2-3):211-8. PubMed ID: 6967756
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of carrageenan on the induction of cell-mediated cytotoxic responses in vivo.
    Sakemi T; Kuroiwa A; Nomoto K
    Immunology; 1980 Oct; 41(2):297-302. PubMed ID: 6969217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.
    Fidler IJ; Gersten DM; Budmen MB
    Cancer Res; 1976 Sep; 36(9 pt.1):3160-5. PubMed ID: 975082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells.
    Todd RF; Stulting RD; Berke G
    Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536
    [No Abstract]   [Full Text] [Related]  

  • 30. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of T cell-mediated cytotoxicity by anti-inflammatory steroids.
    Schleimer RP; Jacques A; Shin HS; Lichtenstein LM; Plaut M
    J Immunol; 1984 Jan; 132(1):266-71. PubMed ID: 6606668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the mechanism of lymphocyte-mediated cytolysis. V. The use of cytochalasins A and B to dissociate glucose transport from the lytic event.
    Bubbers JE; Henney CS
    J Immunol; 1975 Jul; 115(1):145-49. PubMed ID: 807622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture.
    Ehrke MJ; Ryoyama K; Cohen SA
    Cancer Res; 1984 Jun; 44(6):2497-504. PubMed ID: 6426781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined effect of X irradiation and cell-mediated immune reaction.
    Song CW; Guertin DP
    Radiat Res; 1978 Sep; 75(3):586-92. PubMed ID: 103127
    [No Abstract]   [Full Text] [Related]  

  • 35. 7'-(3',4'-dihydroxyphenyl)-N-[(4-methoxyphenyl)ethyl]propenamide (Z23), an effective compound from the Chinese herb medicine Fissistigma oldhamii (Hemsl.) Merr, suppresses T cell-mediated immunity in vitro and in vivo.
    Hu XD; Zhong XG; Zhang XH; Zhang YN; Zheng ZP; Zhou Y; Tang W; Yang Y; Yang YF; Hu LH; Zuo JP
    Life Sci; 2007 Dec; 81(25-26):1677-84. PubMed ID: 18022200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of organophosphorus inhibitors, p-nitrophenol and cytochalasin B on cytotoxic killing of tumour cells by immune spleen cells, and the effect of shaking.
    Ferluga J; Asherson GL; Becker EL
    Immunology; 1972 Oct; 23(4):577-90. PubMed ID: 4628464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of inhibitor-antioxidant of 3-hydroxypyridine series on cellular immunity].
    Suzdal'tseva AA; Kapichnikov MM; Shalyminova IuA; Zykov IuV; Smirnov LD
    Biull Eksp Biol Med; 1982 Feb; 93(2):49-50. PubMed ID: 7066526
    [No Abstract]   [Full Text] [Related]  

  • 38. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo suppression of the immune response to alloantigen by cholera enterotoxin.
    Henney CS; Lichtenstein LM; Gillespie E; Rolley RT
    J Clin Invest; 1973 Nov; 52(11):2853-7. PubMed ID: 4356000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo.
    Anaclerio A; Waterfield JD; Möller G
    J Immunol; 1974 Sep; 113(3):870-5. PubMed ID: 4413847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.